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Antidepressive therapy with escitalopram improves mood,
cognitive symptoms, and identity memory for angry faces in
elderly depressed patients
Abstract
Depression is a common disorder in the elderly handicapping patients with affective and cognitive
symptoms. Because of their good tolerability relative to the older tricyclic compounds, selective
serotonin reuptake inhibitors (SSRIs) are increasingly used for the treatment of depression in the elderly.
Little is known about their effects on cognition in elderly patients. In the present 4-wk, single-centre,
randomized, open-label trial we investigated the antidepressive effects of escitalopram, an SSRI, in 18
elderly depressed patients [mean age (+/-s.e.m.) 76.2+/-1.8 yr] compared to 22 healthy age-matched
controls (mean age 76.9+/-1.8 yr). Affective and cognitive symptoms were assessed using the Geriatric
Depression Scale (GDS), Mini-Mental State Examination (MMSE), and a face portrait recognition test
to assess memory for happy and angry faces. Depressed patients prior to treatment had markedly
reduced memory performance. Treatment with escitalopram improved affective and cognitive symptoms
significantly. Furthermore, escitalopram treatment improved memory for negative facial stimuli. Control
subjects confirmed the well- established memory bias favouring recognition of identities acquired with
happy expressions. Importantly, this bias was absent in depressed patients prior to, but also after
treatment. In conclusion, escitalopram, even after a relatively short treatment period, was effective in
treating depression in the elderly and may help improve cognitive performance for social stimuli.
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Abstract
Depression is a common disorder in the elderly handicapping patients with aﬀective and cognitive
symptoms. Because of their good tolerability relative to the older tricyclic compounds, selective serotonin
reuptake inhibitors (SSRIs) are increasingly used for the treatment of depression in the elderly. Little is
known about their eﬀects on cognition in elderly patients. In the present 4-wk, single-centre, randomized,
open-label trial we investigated the antidepressive eﬀects of escitalopram, an SSRI, in 18 elderly depressed
patients [mean age (¡S.E.M.) 76.2¡1.8 yr] compared to 22 healthy age-matched controls (mean age
76.9¡1.8 yr). Aﬀective and cognitive symptomswere assessed using the Geriatric Depression Scale (GDS),
Mini-Mental State Examination (MMSE), and a face portrait recognition test to assess memory for happy
and angry faces. Depressed patients prior to treatment had markedly reduced memory performance.
Treatment with escitalopram improved aﬀective and cognitive symptoms signiﬁcantly. Furthermore, es-
citalopram treatment improved memory for negative facial stimuli. Control subjects conﬁrmed the well-
established memory bias favouring recognition of identities acquired with happy expressions.
Importantly, this bias was absent in depressed patients prior to, but also after treatment. In conclusion,
escitalopram, even after a relatively short treatment period, was eﬀective in treating depression in the
elderly and may help improve cognitive performance for social stimuli.
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Introduction
Mood disorders are associated with cognitive abnor-
malities, especially in the perception and consoli-
dation of emotional stimuli (Leppa¨nen, 2006). In
addition, depressed individuals exhibit impaired
social functioning (Cooley and Nowicki, 1989) mainly
due to the accompanying cognitive deﬁcits, which
handicap interpersonal processes (Hale, 1998 ; Pine
et al., 2004). According to the dominant cognitive
paradigm for depression, Beck’s model, maladaptive
cognition is implicated in both the aetiology and
maintenance of the depressive process (Beck et al.,
1979). Depressed individuals have the tendency to
appraise themselves, others and their daily events
with negative expectancies (Beck et al., 1979 ;
Lewinsohn et al., 1981), and to selectively recall nega-
tive information or exhibit an attentional bias towards
negative emotional cues, a ﬁnding known as abnormal
or negative emotional memory bias of depression
(Bradley et al., 1995 ; Gotlib et al., 2004 ; Leppa¨nen,
2006 ; Surguladze et al., 2004 ; Zakzanis et al., 1998).
Additionally, depressive patients tend to attribute
negative events (Sweeney et al., 1986) and negative
self-evaluations to themselves (Giesler et al., 1996).
Depressive individuals speciﬁcally endorse and recall
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less positive information and organize positive self-
relevant information with less interconnectedness
than anxious individuals and controls, suggesting
that they have an interconnected negative self-
representational system and lack a well-organized
positive template of self (Dozois and Dobson, 2001).
Thus, dysfunctional interpersonal interactions, as a
consequence of negative bias, may sustain depression
symptoms (Coyne et al., 1991). Depressive persons
elicit support behaviour, intermixed with rejection at-
titudes, from persons in their general surroundings,
and continuously increase their support-seeking be-
haviour until these persons eventually withdraw.
Interpersonal interactions of depressive persons, such
as giving or receiving social support, are heavily im-
paired (McNaughton et al., 1992), and their readiness
to perceive and attend to negative aspects in inter-
personal relationships may lead to decreased social
support (Gotlib and Hammen, 1992). Finally, this mal-
adaptive process contributes decisively to increased
risk of depression chronicity (Brown et al., 1994). In
addition, abnormalities in the processing of emotional
information heighten the risk of the development of
mood disorders (Leppa¨nen, 2006). Therefore, under-
standing the negative aspects of the cognitive pro-
cesses that lead to maladaptive interpersonal
interactions in depression and improvement of these
cognitive diﬃculties may help patients.
Facial expressions are stimuli with a high arousal
eﬀect and the recognition of emotional facial ex-
pressions is a perceptual-interpretive process that is
highly developed in human and non-human primates,
reﬂecting its social and behavioural importance
(Rubinow and Post, 1992). Facial expressions of basic
emotions are archetypal social cues that are instantly
recognizable and modulate interpersonal behaviour
(McArthur and Baron, 1983). Cross-cultural studies
indicate that the recognition and expression of basic
emotions in facial expressions show universal simi-
larity (Ekman, 1993). Therefore, facial expressions are
useful tools to employ in the study of cognitive pro-
cesses in interpersonal interactions.
In the present study, using an emotional facial rec-
ognition test, which applies the signal detection and
discrimination paradigm, we investigated the memory
for facial identity in elderly depressive patients before
and after the treatment with a selective serotonin
reuptake inhibitor (SSRI), escitalopram. Since de-
pression is a common disorder in the elderly greatly
disabling them in their individual and social behav-
iour, we hypothesize that antidepressive treatment
with escitalopram may improve the cognitive para-
meters contributing to the recovery process. The main
hypotheses of this investigation were : (1) Depressive
patients have impaired identity recognition memory
compared to healthy age-matched control subjects.
(2) Elderly control subjects show the well-documented
emotional expression bias that they better recognize
happy identities. (3) Depressive patients do not show
this bias. (4) Treatment of depressive patients with
escitalopram improves aﬀective and global cognitive
scores. (5) Treatment of depressive patients with
escitalopram restores identity recognition memory
deﬁcits. (6) Improvement of depression correlates with
improvement of memory.
Method
Study design
The present study was a 4-wk, single-centre, open-
label trial to assess the eﬀects of treatment with
escitalopram on aﬀective and cognitive symptoms,
and on memory for facial identity in elderly depressed
patients compared to healthy age-matched controls.
The protocol was approved by the local Ethics
Committee and conformed to the provisions of the
Declaration of Helsinki. Written informed consent
was obtained, and full and adequate oral and written
information about the objectives of the study, possible
therapeutical advantages and side-eﬀects were given
to the participants.
The inclusion criteria were a conﬁrmed diagnosis
of a current depressive episode according to ICD-10
criteria (major depression, ﬁrst episode), permanent
medical or social care available during the study,
written informed consent and age >65 years. The
exclusion criteria included known sensitivity to escit-
alopram, evidence of severe and/or chronic renal,
hepatic, cardiovascular, pulmonary or gastrointestinal
impairment or cancer, other psychiatric disorders or
dementia, drug abuse, concomitant medication with
clonidine or beta-blockers, and participation in any
other drug trial. Subjects were free to withdraw their
informed consent at any time, without prejudice to
further treatment.
Patient data was collected during three visits. Visit
1 : during the run-in period for baseline assessments
to check inclusion and exclusion criteria ; visit 2, 1 d
prior to commencing study drug, and visit 3 at the
end of the fourth week of treatment. The facial
picture recognition test and the additional psycho-
metric test battery were performed twice during
visits 2 and 3 in depressed patients. Since all patients
with depression were in-patients, they all underwent
a routine physical and laboratory examination
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and electrocardiogram during the baseline period.
Healthy elderly controls were assessed only during
visits 1 and 2, and the facial picture recognition test
and the additional psychometric tests were performed
once during visit 2.
Patients and control subjects
All patients with depression were in-patients hospi-
talized on the gerontopsychiatric ward. Twenty-two
patients were included in the study. Four patients
dropped out during the course of the study because
of withdrawal of informed consent, evidence of psy-
chotic symptoms or acute infection. Thus, a total of 18
patients ﬁnished the 4-wk treatment period and could
be evaluated: 14 women and 4 men (Table 1), mean
age (¡S.E.M.) 76.2¡1.8 yr. Additionally, 22 elderly
controls, 16 women and 6 men, were included in the
study (mean age 76.9¡1.8 yr), who were recruited by
local advertisement and from retirement homes. Only
healthy elderly participants were included in the
study without acute or chronic severe diseases which
was conﬁrmed by physical examination and a report
from their medical caregivers.
Medication
Concomitant medication was allowed with the excep-
tion of clonidine and beta-blockers. Concomitant psy-
chiatric medication, especially benzodiazepines and
hypnotics, were only allowed during the initial acute
phase of the depression starting after visit 2 assess-
ments. Then concomitant psychiatric medication was
withdrawn during the next 2 wk of treatment.
Escitalopram was chosen as the antidepressive medi-
cation since the R-enantiomer present in citalopram
has been suggested to reduce the eﬃcacy of S-
enantiomer (escitalopram) which is mainly respon-
sible for the serotonin reuptake inhibitory activity
of the compound (Sa´nchez et al., 2004). The starting
dose was 5 mg, which was increased in 5-mg
steps every 1–2 wk, based on the clinical judgement
of the investigators. The maximum allowed dose of
escitalopram was 20 mg.
Experimental stimuli and facial picture
recognition test
For testing the memory for facial identity picture
photographs of male faces with happy (positive) or
angry (negative) expressions were presented on a com-
puter screen approximately 60 cm in front of the seated
participants. The two emotional expressions ‘happy’
and ‘angry’ were chosen because of their high social
relevance in approach and avoidance dimensions. The
generation of test material is described in detail in
a previous study (Savaskan et al., 2007).
Participants were asked to look carefully at the
presented faces, and especially observe their charac-
teristics and emotional expressions, in order to recog-
nize them later in the second part of the test. For the
encoding task, participants saw 30 randomly assorted
faces with angry or happy expressions of 30 diﬀerent
subjects. Each picture was presented for 10 s, and
there was a 3-s interval between each picture, appear-
ing as a white screen. After a 10-min retention interval,
60 faces were presented to the participants in the
recognition task, all with neutral expression. Thirty
pictures included in the recognition task were the
neutral faces of 30 individuals presented during the
encoding task and the remaining 30 pictures showed
new faces. After each picture participants were asked
to identify each face as old or new.
Then the sensitivity index d’ from signal detection
theory was calculated to get a bias-free measure of
memory strength for identity recognition (Wickens,
2002). For identity recognition an overall hit and false-
alarm rate and two expression-speciﬁc hit rates were
calculated for each subject. These values were used to
calculate d’ as z(hit rate) – z(false alarm rate) for the
overall and the two expression-speciﬁc recognition
performances for each subject. To compare memory
performances between and within the diﬀerent groups
several ANOVAs were conducted with d’ as the de-
pendent variable. As escitalopram was expected to
improve cognitive function and memory, hypothesis
5 was tested with a-priori constructed, one-sided con-
trast based on t tests. A x2 test was used to explore
the memory bias for faces acquired with happy ex-
pression. Eﬀects of subject education were assessed by
Student’s t test and Mann–Whitney U test again with
d’ as the dependent variable.
Psychometric test battery
Geriatric Depression Scale (GDS)
The GDS was originally devised by gathering 100
questions relating to depression in older people, and
then selecting the 30 that correlated best with the total
score, and has shown high sensitivity and speciﬁcity
(Yesavage et al., 1983). Each question has a yes/no
answer, with the scoring dependent on the answer
given. Scores >6 indicate a depressive disorder, and
only subjects with scores >6 were included as de-
pressive patients in the study. The mean GDS baseline
scores of the participants was 9.4¡0.4 for elderly de-
pressed patients and 1.2¡0.3 for age-matched controls
(Table 1).
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Mini-Mental State Examination (MMSE)
The MMSE is probably the most widely used as-
sessment scale for cognitive functioning and was
originally created to diﬀerentiate organic from func-
tional organic disorders (Folstein et al., 1995). The
MMSE has a maximum score of 30 points, with dif-
ferent domains assessed: orientation to time and
Table 1. Demographic data and results of psychometric tests of study participants
Case Age Sex Education MMSE-1 MMSE-2 GDS-1 GDS-2 SSRI
Depressive patients
1 69 F 1 25 25 10 6 15
2 84 F 2 25 27 12 7 20
3 82 F 2 30 29 8 2 15
4 71 F 2 26 25 8 6 15
5 70 F 2 24 27 10 3 15
6 87 F 1 25 24 7 2 10
7 77 F 2 30 30 9 3 15
8 66 M 2 25 27 12 8 20
9 83 F 2 28 30 12 7 20
10 79 F 2 23 28 7 3 15
11 85 F 2 27 30 10 5 15
12 66 F 3 29 29 8 2 15
13 87 F 3 28 27 7 3 20
14 74 M 3 29 30 8 3 10
15 76 F 3 26 29 11 6 20
16 65 F 2 27 28 10 4 20
17 79 M 2 28 29 8 2 15
18 72 M 3 29 30 12 12 15
Elderly controls
1 65 F 3 30 – 0 – –
2 66 F 3 29 – 1 – –
3 67 M 3 28 – 0 – –
4 67 F 2 28 – 0 – –
5 68 F 2 30 – 0 – –
6 69 F 2 30 – 0 – –
7 69 F 3 30 – 1 – –
8 70 F 2 30 – 0 – –
9 71 M 2 30 – 0 – –
10 71 M 3 29 – 0 – –
11 78 F 3 30 – 1 – –
12 80 M 2 27 – 1 – –
13 81 F 2 29 – 3 – –
14 82 F 2 30 – 1 – –
15 83 F 1 28 – 6 – –
16 85 F 1 28 – 3 – –
17 89 F 2 30 – 1 – –
18 91 F 2 28 – 2 – –
19 85 F 2 29 – 0 – –
20 89 F 1 29 – 4 – –
21 82 M 2 26 – 2 – –
22 83 M 3 30 – 0 – –
Education: (1) primary, (2) secondary, (3) tertiary ; MMSE-1, Mini-Mental-State-
Examination baseline ; MMSE-2, after 4 wk of treatment with SSRI ; GDS-1, Geriatric
Depression Scale baseline ; GDS-2, after 4 wk of treatment with SSRI ; SSRI, maximum
dose (mg) of escitalopram.
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place, registration of three words, attention and cal-
culation, recall of three words, language and visual
construction. Scores <26 indicate cognitive dis-
turbances and need further evaluation to exclude or-
ganic or non-organic cognitive disorders. The MMSE
was performed twice in depressed patients at baseline
and after 4-wk treatment period to assess cognitive
improvement. Since all patients were in-patients, those
patients with a MMSE score<26 underwent a routine
dementia screening procedure including neuroim-
aging and a Consortium to Establish a Registry for
Alzheimer’s Disease (CERAD) test battery to exclude
dementia. The mean MMSE baseline scores of the
participants were 26.9¡0.5 for elderly depressed pa-
tients and 29¡0.2 for age-matched controls (Table 1).
Results
Demographic data and the results of GDS and MMSE
assessments are summarized in Table 1. Eighteen eld-
erly depressed patients (excluding four drop-outs)
and 22 age-matched controls were evaluated. No sev-
ere adverse events were observed during the therapy
with escitalopram in depressed patients. Three pa-
tients complained of mild adverse events such as gas-
trointestinal discomfort and nausea in the ﬁrst week of
the antidepressive therapy. Two patients had urinary
infections during the treatment period and were treat-
ed with norﬂoxacin for 5 d. However, none of these
two patients had antibiotic therapy during the visit 3
assessments. The mean dose of escitalopram at the end
of the 4-wk treatment period was 16.1¡0.8 mg.
ANOVA was performed with the between-subject
factor ‘group’ and the within- subject factor ‘emotion-
al expression’ – the latter based on d’ values calcu-
lated separately for acquired faces with happy and
angry expression – and revealed that depressive pa-
tients have lower identity recognition memory per-
formance than healthy age-matched control subjects
(hypothesis 1) (F1,38=4.6, p=0.038 ; see also Figure 1).
When examining this diﬀerence in more detail it ap-
peared that this diﬀerence was mainly due to memory
performance of identities acquired with happy facial
expressions (p=0.018, see Figure 1).
Subjects in the control group had a better recog-
nition of identities with a happy facial expression
(hypothesis 2) (p=0.046, see Figure 1). This, however,
was not the case for depressed patients, neither before,
nor after treatment with escitalopram (hypothesis 3).
There were seven out of 22 control subjects who had a
better identity recognition for faces acquired with an-
gry expression and 15 who had a better or equal
identity recognition for faces acquired with happy
expression. However, 11 out of 18 depressed patients
showed better identity recognition for faces acquired
with angry expression and seven did not show
this behaviour. An a-priori constructed one-sided x2
test was based on this distribution and revealed stat-
istical signiﬁcance (p=0.03). Thus, with respect to
the well-established identity recognition memory bias,
depressed patients failed to respond to happy-face
stimuli.
Within the treatment group GDS scores improved
signiﬁcantly from baseline (p<0.0001) after the 4-wk
treatment period (hypothesis 4). Group mean scores
were 9.4 (¡0.4) before and 4.7 (¡0.6) after treatment.
MMSE values also improved signiﬁcantly (p=0.023)
after treatment from 26.8 (¡0.5) to 27.9 (¡0.4).
Treatment of depressive patients with escitalopram
did not improve identity recognition memory for faces
acquired with happy expression. However, escitalo-
pram improved identity recognition memory for faces
acquired with angry expression. Before treatment
the mean d’ was 0.46 (¡0.13), and after treatment it
was 0.62 (0.1, p=0.05) (hypothesis 5). Individual im-
provement (change in GDS or MMSE scores) after
treatment with escitalopram did not signiﬁcantly cor-
relate with changes in identity recognition perform-
ance (hypothesis 6).
Discussion
The present study shows signiﬁcant eﬀects of
antidepressive therapy on aﬀective and cognitive
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Figure 1. Identity recognition memory performance of
normal control subjects (Con) and depressed patients (Dep)
prior to treatment with escitalopram. Overall, the memory
performance of control subjects is better than that of
depressed patients (p=0.038). This diﬀerence is pronounced
when only faces with happy expression are considered
(p=0.018). Control age-matched subjects have better
recognition memory performance for identities with happy
facial expression vs. angry facial expression. However, this
was not the case for depressed patients.
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parameters in elderly depressed patients as shown by
GDS and MMSE results. In addition, antidepressive
therapy was able to improve memory for facial ident-
ity for negative stimuli. The main ﬁndings at baseline
were a general reduction in memory performance in
elderly depressed patients and a bias towards positive
(happy) facial identities in healthy elderly controls.
The latter is in accordance with our previous ﬁndings
in healthy elderly subjects (Savaskan et al., 2007).
Happy faces were found to be better recognized in all
observed age groups (young adults : 20–40 yr ; elderly
adults : 60–80 yr ; and very old adults : >80 yr) than
angry faces (Savaskan et al., 2007). Although there was
a continuous overall decrease in recognition of both
happy and angry faces with advanced age in those
healthy individuals, the eﬀect favouring happy facial
expressions was found to be stable in old and very old
adults. Decreased facial identity recognition was sug-
gested to underlie diﬃculties in emotion processing in
the elderly, and to contribute to behavioural and social
diﬃculties in their daily life.
Although there was a positive bias towards happy
facial identities in age-matched control subjects, this
was not observed in patients with depression prior to
and after the treatment period in the present study.
Thus, 61.1% of patients with depression showed a
better identity recognition for faces with angry ex-
pression, whereas only 31.8% of control subjects
showed this behaviour. This is in accordance with
previous studies suggesting a negative cognitive bias
in depressed patients : a review summarizing the re-
sults of studies investigating emotional information
processing in mood disorders has shown this negative
bias for young depressed patients (Leppa¨nen, 2006).
In addition, young depressed patients were shown to
have a general impairment in displaying emotional
facial expressions (Wexler et al., 1994), and were
generally impaired in the recognition of aﬀect in the
facial expressions (Rubinow and Post, 1992). Their
interpersonal diﬃculties have been suggested to be
strongly linked to the fact that they exhibit diﬃculty in
accurately decoding facial expressions of emotions as
well as in their behavioural and emotional responses
to these expressions (Persad and Polivy, 1993). Young
depressed patients, relative to the non-depressed
controls, were found to make more errors in re-
cognizing facial expressions and reported more
tensing, higher fear and depression reactions, and
feeling less comfortable with their own emotional re-
actions.
In general, emotion perception is disproportionately
negatively aﬀected relative to other cognitive functions
in depressed patients (Langenecker et al., 2005), and
depressed patients show subtle impairments in
discrimination accuracy and predominant bias away
from the identiﬁcation of happy expressions
(Surguladze et al., 2004). On the other hand, clinically
stabilized depressed in-patients were signiﬁcantly
slower in responding to positive faces than normal
subjects, whereas they did not show performance
diﬀerences in the detection of negative faces, suggest-
ing that depressive mood may also be associated with
a reduced spatial attention to positive facial expression
(Suslow et al., 2001). Moreover, some of these abnor-
malities in the processing of emotional information
persisted after symptom remission (Leppa¨nen, 2006).
This may explain why patients failed to improve
their recognition of happy facial expressions after the
treatment period in the present study. Another factor
may be that depressive patients require signiﬁcantly
greater intensity of emotion than control subjects to
correctly identify happy expressions (Joormann and
Gotlib, 2006). Interestingly, poorer memory perform-
ance for emotional facial expressions was signiﬁcantly
associated with larger left amygdala volumes in de-
pressed patients taking antidepressant medication
(Weniger et al., 2006).
One limitation of the present study may be the
dominance of female subjects in both groups which
represents the demographics of the main population
in this age group. In a previous study gender eﬀects
were reported on memory for facial identity : women
were found to identify more male faces correctly than
female faces, irrespective of the emotion expressed
(Rahman et al., 2004). Since only pictures of male faces
were included in the present study, this eﬀect may not
limit study results. Two other studies demonstrated a
female advantage across emotions regardless of the
sex of the face presented (Campbell et al., 2002 ; Thayer
and Jonsen, 2000) whilst one reported that the sex of
the subject interacted with the sex of the face (Erwin
et al., 1992). Women were found to be more sensitive
to happiness in male faces (Erwin et al., 1992) whereas
later data have shown women to be more accurate at
identifying male faces regardless of emotion (Rahman
et al., 2004). Nevertheless, our previous data have
shown that gender-related diﬀerences in facial identity
may not have a signiﬁcant impact in the elderly
(Savaskan et al., 2007).
There was a signiﬁcant improvement from baseline
in GDS and MMSE scores during the 4-wk treatment
period in the present study, and escitalopramwas well
tolerated. Mild adverse events such as gastrointestinal
discomfort and nausea were observed in three of the 22
patients within the ﬁrst week of treatment. The eﬀects
of citalopram on cognitive processing of emotional
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cues have been studied previously in healthy young
volunteers (Harmer et al., 2003, 2004). Volunteers re-
ceiving a single dose of citalopram were found to
detect a higher number of facial expressions of fear
and happiness, with reduced response times, relative
to those given a placebo (Harmer et al., 2003).
Citalopram also reduced the identiﬁcation of the
negative facial expressions of anger and fear after 7 d
treatment, and abolished the increased startle re-
sponse found in the context of negative aﬀective im-
ages (Harmer et al., 2004). In addition, it increased the
relative recall of positive (vs. negative) emotional
material. Thus, volunteers receiving citalopram for 7 d
showed decreased amygdala responses to masked
presentations of threat compared to placebo, and
citalopram was able to reduce responses within the
hippocampus andmedial prefrontal cortex speciﬁcally
during the fear-relevant stimuli (Harmer et al., 2006).
Interestingly, there was no eﬀect of citalopram on the
neural or behavioural response to happy facial ex-
pressions in the latter study. These results suggest a
direct eﬀect of serotonin potentiation on amygdala
response to threat-relevant stimuli in humans. Since
elderly depressed patients were investigated, not only
age, but also the diﬀerential eﬀects of escitalopram
therapy on emotional processing of negative or posi-
tive stimuli may account for the failure of these pa-
tients to show a positive bias after the treatment period
in the present study. It has been suggested that anti-
depressant therapy may not directly aﬀect mood but
may initiate a cascade of changes in emotional pro-
cessing, which ultimately aﬀects low mood and anxi-
ety through changes in social reinforcement and the
detection of environmental threat (Harmer et al.,
2006). Elderly subjects have an overall reduction in
cognitive performance for identity memory (Savaskan
et al., 2007), and therefore, elderly patients might need
a longer treatment period to overcome the memory
deﬁcits for emotional stimuli. However, the positive
eﬀect of the SSRI on cognitive processing of negative
stimuli may provide an additional clue in the treat-
ment of depression.
In conclusion, the present data show that elderly
depressed patients have not only aﬀective and overall
cognitive symptoms, but also deﬁcits in facial
identity recognition memory, especially for identities
with happy facial expressions. This may provide
a critical performance deﬁcit complicating interper-
sonal behaviour diﬃculties in depressed patients.
Antidepressant therapy with escitalopram improved
mood, overall cognitive performance and the memory
for negative facial stimuli, but not for positive stimuli.
The SSRI treatment seems to be eﬀective in decreasing
the negative bias of depression and may help improve
patients’ maladaptive social interactions.
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